|

Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment

RECRUITINGN/ASponsored by KU Leuven
Actively Recruiting
PhaseN/A
SponsorKU Leuven
Started2024-08-01
Est. completion2026-08-01
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06346080

Summary

The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question it aims to answer are: * Which diagnostic modality is preferred by patients and the general population? * Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality? * Are geographical differences present in regard to the preference for a diagnostic modality? Participants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio-economic status. This approach will allow us to correct for confounding factors.

Eligibility

Age: 18 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Individuals \>18yo to 75yo (upper age limit of Barrett's surveillance)
2. Access to computer or smartphone
3. Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese)

Exclusion Criteria:

1. Individuals less than 18yo and more than 75yo
2. Incarcerated individuals

Conditions3

CancerEsophageal CancerGastric Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.